| Literature DB >> 29222431 |
Fátima Arrutia1, Rebeca Fernández2, Carlos Menéndez3, Ulises A González3, Francisco A Riera2.
Abstract
In order to exploit industrial discards, protein enzymatic hydrolysis is a currently popular methodology for obtaining bioactive peptides. However, once released, most promising peptides have to be selected from the mixture. In this work, the suitability of pepsin (EC 3.4.23.1) to hydrolyse serum albumin in order to obtain bioactive peptides was assessed. Then, a suitable process to obtain best separation of bioactive peptides was evaluated, using polyethersulfone membranes at different pH values. Serum albumin was easily hydrolysed by pepsin, reaching a DH value of the 65.64 ± 1.57% of the maximum possible. A 23.25% of the identified peptides possessed high bioactivity scores (greater than 0.5), and one of them had reported bioactivity (LLL). Charge mechanisms always predominated over the sieve effect, and best transmission was accomplished at pH values close to the peptides isoelectric points. Basic and neutral peptides with the highest scores were always the most transmitted. Membrane material had greater influence than NMWCO in determining peptide transmission. In order to obtain purified fractions rich in peptides with high bioactivity scores from serum albumin, polyethersulfone membranes (applicable to industrial scale) of 5 kDa MWCO should be used at basic pH values after pepsin digestion.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29222431 PMCID: PMC5722935 DOI: 10.1038/s41598-017-17029-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Hydrolysis curve for BSA (3 g/L) digestion with pepsin (4% E:S ratio) at 37 °C and pH 2. Data are presented as mean ± error.
Peptides identified by LC-MS/MS in the BSA peptic hydrolysate (3 g/L) and membrane permeates, plus relevant physiochemical characteristics. Peptide sequences are arranged by group type. Each group is arranged in descending order by potential bioactivity.
| MW (Da) | Peptide sequence | Charge pH = 2a | Charge pH = 10b | Groupc | GRAVYd | Bioactivity Scoree |
|---|---|---|---|---|---|---|
| 592.30 | (F)/YAPEL/(L) | 0.90 | −2.50 | A | −0.16 | 0.38 |
| 471.28 | (A)/PELL/(Y) | 0.90 | −2.00 | A | 0.63 | 0.34 |
| 639.28 | (E)/ACFAVE/(G) | 0.90 | −3.00 | A | 0.87 | 0.34 |
| 634.34 | (A)/PELLY/(Y) | 0.90 | −2.50 | A | 0.24 | 0.32 |
| 596.29 | (E)/YEATL/(E) | 0.90 | −2.50 | A | 0.02 | 0.13 |
| 424.21 | (Y)/LYE/(I) | 0.90 | −2.50 | A | −0.33 | 0.11 |
| 389.20 | (E)/EQL/(K) | 0.90 | −2.00 | A | −1.07 | 0.07 |
| 483.21 | (E)/YEAT(L) | 0.90 | −2.50 | A | −0.93 | 0.06 |
| 362.19 | (E)/LTE/(F) | 0.90 | −2.00 | A | −0.13 | 0.04 |
| 346.20 | (F)/VEV(T) | 0.90 | −2.00 | A | 1.63 | 0.02 |
| 1059.58 | (E)/IARRHPYF/(Y) | 3.90 | 0.50 | B | −0.75 | 0.73 |
| 731.42 | (A)/WSVARL/(S) | 1.90 | 0.00 | B | 0.60 | 0.68 |
| 517.28 | (L)/HTLF/(G) | 1.90 | −1.00 | B | 0.68 | 0.59 |
| 401.29 | (L)/LRL/(A) | 1.90 | 0.00 | B | 1.03 | 0.56 |
| 1081.57 | (L)/SQKFPKAEF/(V) | 2.90 | −1.00 | B | −1.09 | 0.53 |
| 1075.52 | (Y)/YANKYNGVF/(Q) | 1.90 | −1.50 | B | −0.57 | 0.45 |
| 1122.65 | (L)/PKLKPDPNTL/(C) | 2.90 | −1.00 | B | −1.27 | 0.43 |
| 1238.58 | (L)/YYANKYNGVF/(Q) | 1.90 | −2.00 | B | −0.64 | 0.43 |
| 825.45 | (E)/TYVPKAF/(D) | 1.90 | −1.00 | B | 0.19 | 0.30 |
| 1107.53 | (E)/YSRRHPEY/(A) | 3.90 | −1.00 | B | −2.59 | 0.28 |
| 550.33 | (L)/IVRY/(T) | 1.90 | −0.50 | B | 0.73 | 0.20 |
| 893.48 | (P)VSEKVTKC(C) | 2.90 | −2.00 | B | −0.24 | 0.10 |
| 478.27 | (L)/KTVM(E) | 1.90 | −0.50 | B | 0.38 | 0.09 |
| 801.52 | (Q)/IKKQTAL/(V) | 2.90 | 0.00 | B | −0.27 | 0.09 |
| 1051.62 | (L)/LKHKPKATE/(E) | 4.90 | −0.50 | B | −1.68 | 0.08 |
| 838.48 | (E)/HVKLVNE/(L) | 2.90 | −1.50 | B | −0.27 | 0.05 |
| 1546.91 | (L)/IVRYTRKVPQVST(P) | 3.90 | 1.00 | B | −0.34 | 0.05 |
| 414.20 | (L)/FTF/(H) | 0.90 | −1.00 | N | 1.63 | 0.97 |
| 350.21 | (L)/IAF/(S) | 0.90 | −1.00 | N | 3.03 | 0.82 |
| 514.23 | (E)/YGFQ/(N) | 0.90 | −1.50 | N | −0.60 | 0.79 |
| 358.27 | (W)/LLL/(L) | 0.90 | −1.00 | N | 3.80 | 0.57 |
| 336.19 | (F)/VAF/(V) | 0.90 | −1.00 | N | 2.90 | 0.56 |
| 423.22 | (L)/GLAY/(P) | 0.90 | −1.50 | N | 0.98 | 0.46 |
| 330.20 | (T)PTL/(V) | 0.90 | −1.00 | N | 0.50 | 0.35 |
| 713.42 | (F)/AVEGPKL/(V) | 1.90 | −1.50 | N | 0.06 | 0.30 |
| 474.27 | (D)RADL/(A) | 1.90 | −1.00 | N | −0.60 | 0.26 |
| 382.20 | (D)YLS(L) | 0.90 | −1.50 | N | 0.57 | 0.24 |
| 940.48 | (E)/TYVPKAFD(E) | 1.90 | −2.00 | N | −0.28 | 0.17 |
| 488.31 | (Y)/AVSVL/(L) | 0.90 | −1.00 | N | 2.64 | 0.12 |
| 700.42 | (L)/LPKIET(M) | 1.90 | −1.50 | N | −0.23 | 0.10 |
| 417.27 | (A)/VSVL/(L) | 0.90 | −1.00 | N | 2.85 | 0.08 |
| 688.43 | (F)/VEVTKL/(V) | 1.90 | −1.50 | N | 0.68 | 0.05 |
| 533.29 | (L)/VVSTQ/(T) | 0.90 | −1.00 | N | 0.68 | 0.03 |
a,b,dCalculated with the Expasy Molecular Biology Server (http://www.expasy.org/).
cCalculated as in Lapointe, et al.[44].
eCalculated with Peptide Ranker in silico tool (http://bioware.ucd.ie/∼compass/biowareweb/).
Figure 2Observed and theoretical transmission values across PES1 membrane for BSA peptic hydrolysate identified peptides. Data are presented as mean ± error.
Figure 3Observed and theoretical transmission values across PES5 membrane for BSA peptic hydrolysate identified peptides. Data are presented as mean ± error.
Separation factors for all the combinations membrane-pH assayed.
| pH2 | pH10 | |||
|---|---|---|---|---|
| PES1 | PES5 | PES1 | PES5 | |
| A/N | 135.92 | 102.52 | 1691.30 | 3765.36 |
| A/B | 1049.77 | 428.95 | 1962.46 | 4189.63 |
| B/N | 1426.88 | 418.43 | 116.03 | 111.27 |
A = acid peptides; B = basic peptides; N = neutral peptides.